AG
ONCS

Advisor Group’s OncoSec Medical Incorporated ONCS Stock Holding History

Advisor Group’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$0 Hold
3
– – ﹤0.01% 5641
2019
Q3 		$0 Hold
3
– – ﹤0.01% 5600
2019
Q2 		$0 Hold
3
– – ﹤0.01% 5521
2019
Q1 		$0 Hold
3
– – ﹤0.01% 5436
2018
Q4 		$0 Hold
3
– – ﹤0.01% 5363
2018
Q3 		$1K Hold
3
– – ﹤0.01% 5053
2018
Q2 		$1K Buy
+3
New +$1.05K ﹤0.01% 4878
2018
Q1 		– Sell
-32
Closed -$12K – 5164
2017
Q4 		$12K Buy
+32
New +$11.2K ﹤0.01% 4013

Other funds holding ONCS

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Advisor Group's ONCS Position: Q4 2019 in Review

Advisor Group held its OncoSec Medical Incorporated (ONCS) position steady in Q4 2019 at 3 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5641.

Advisor Group first reported a position in ONCS in Q4 2017 and has held it in 8 quarters since. The position peaked at $12K in Q4 2017. 20 funds tracked by Wall St. Rank hold ONCS as of Q4 2019.

  • Advisor Group held 3 shares of OncoSec Medical Incorporated worth $0 as of Q4 2019.
  • Advisor Group left its OncoSec Medical Incorporated share count unchanged in Q4 2019.
  • OncoSec Medical Incorporated made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5641 holding.
  • Advisor Group first reported a position in OncoSec Medical Incorporated in Q4 2017 and has held it in 8 quarters since.
  • Advisor Group's OncoSec Medical Incorporated position peaked at $12K in Q4 2017.
  • 20 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.